These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21762932)

  • 21. Atorvastatin increases myocardial indices of oxidative stress in a porcine model of hypercholesterolemia and chronic ischemia.
    Sodha NR; Boodhwani M; Ramlawi B; Clements RT; Mieno S; Feng J; Xu SH; Bianchi C; Sellke FW
    J Card Surg; 2008; 23(4):312-20. PubMed ID: 18598320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overfed Ossabaw swine with early stage metabolic syndrome have normal coronary collateral development in response to chronic ischemia.
    Lassaletta AD; Chu LM; Robich MP; Elmadhun NY; Feng J; Burgess TA; Laham RJ; Sturek M; Sellke FW
    Basic Res Cardiol; 2012 Mar; 107(2):243. PubMed ID: 22231675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inducible cyclooxygenase expression mediating hypoxia/reoxygenation-induced pulmonary vasoconstriction is attenuated by a cyclooxygenase inhibitor in rats.
    Su CL; Yuan DW; Chiang LL; Lee HL; Chen KH; Wang D
    Transplant Proc; 2012 May; 44(4):929-32. PubMed ID: 22564588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calpain inhibition decreases myocardial fibrosis in chronically ischemic hypercholesterolemic swine.
    Potz BA; Sabe AA; Sabe SA; Lawandy IJ; Abid MR; Clements RT; Sellke FW
    J Thorac Cardiovasc Surg; 2022 Jan; 163(1):e11-e27. PubMed ID: 32359903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycogen synthase kinase 3β inhibition reduces mitochondrial oxidative stress in chronic myocardial ischemia.
    Potz BA; Scrimgeour LA; Sabe SA; Clements RT; Sodha NR; Sellke FW
    J Thorac Cardiovasc Surg; 2018 Jun; 155(6):2492-2503. PubMed ID: 29523407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local infiltration of neuropeptide Y as a potential therapeutic agent against apoptosis and fibrosis in a swine model of hypercholesterolemia and chronic myocardial ischemia.
    Matyal R; Sakamuri S; Wang A; Mahmood E; Robich MP; Khabbaz K; Hess PE; Sellke FW; Mahmood F
    Eur J Pharmacol; 2013 Oct; 718(1-3):261-70. PubMed ID: 24051270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of cyclooxygenase-2 inhibitor (celecoxib) on the infarcted heart in situ.
    Yamamoto T; Kakar NR; Vina ER; Johnson PE; Bing RJ
    Pharmacology; 2001 Jul; 63(1):28-33. PubMed ID: 11408829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclooxygenase-2 inhibition improves antioxidative defense during experimental hypercholesterolemia.
    Ahmed S; Gul S; Gul H; Zia-Ul-Haq M; Ercisli S
    Bosn J Basic Med Sci; 2014 May; 14(2):63-9. PubMed ID: 24856376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of celecoxib on cyclooxygenase-1-mediated prostacyclin synthesis and endothelium-dependent contraction in mouse arteries.
    Liu B; Luo W; Zhang Y; Li H; Zhu N; Huang D; Zhou Y
    Eur J Pharmacol; 2013 Jan; 698(1-3):354-61. PubMed ID: 23127498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclooxygenase-2 mediates ischemic, anesthetic, and pharmacologic preconditioning in vivo.
    Alcindor D; Krolikowski JG; Pagel PS; Warltier DC; Kersten JR
    Anesthesiology; 2004 Mar; 100(3):547-54. PubMed ID: 15108967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries.
    Hennan JK; Huang J; Barrett TD; Driscoll EM; Willens DE; Park AM; Crofford LJ; Lucchesi BR
    Circulation; 2001 Aug; 104(7):820-5. PubMed ID: 11502709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COX-2-derived prostacyclin mediates opioid-induced late phase of preconditioning in isolated rat hearts.
    Shinmura K; Nagai M; Tamaki K; Tani M; Bolli R
    Am J Physiol Heart Circ Physiol; 2002 Dec; 283(6):H2534-43. PubMed ID: 12388283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Staphylococcal alpha-toxin provokes coronary vasoconstriction and loss in myocardial contractility in perfused rat hearts: role of thromboxane generation.
    Sibelius U; Grandel U; Buerke M; Mueller D; Kiss L; Kraemer HJ; Braun-Dullaeus R; Haberbosch W; Seeger W; Grimminger F
    Circulation; 2000 Jan 4-11; 101(1):78-85. PubMed ID: 10618308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Canagliflozin Improves Myocardial Perfusion, Fibrosis, and Function in a Swine Model of Chronic Myocardial Ischemia.
    Sabe SA; Xu CM; Sabra M; Harris DD; Malhotra A; Aboulgheit A; Stanley M; Abid MR; Sellke FW
    J Am Heart Assoc; 2023 Jan; 12(1):e028623. PubMed ID: 36583437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response.
    Boodhwani M; Nakai Y; Voisine P; Feng J; Li J; Mieno S; Ramlawi B; Bianchi C; Laham R; Sellke FW
    Circulation; 2006 Jul; 114(1 Suppl):I402-8. PubMed ID: 16820608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calpain inhibition modulates glycogen synthase kinase 3β pathways in ischemic myocardium: A proteomic and mechanistic analysis.
    Potz BA; Sabe AA; Elmadhun NY; Clements RT; Abid MR; Sodha NR; Sellke FW
    J Thorac Cardiovasc Surg; 2017 Feb; 153(2):342-357. PubMed ID: 27986275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycogen Synthase Kinase 3β Inhibition Improves Myocardial Angiogenesis and Perfusion in a Swine Model of Metabolic Syndrome.
    Potz BA; Sabe AA; Elmadhun NY; Clements RT; Robich MP; Sodha NR; Sellke FW
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27405812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypolipidemic effects of nimesulide and celecoxib in experimentally induced hypercholesterolemia in rabbits.
    Ahmed S; Gul S; Zia-ul-Haq M; Riaz M
    Turk J Med Sci; 2015; 45(2):277-83. PubMed ID: 26084115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blockade of angiotensin signaling improves myocardial function in hypercholesterolemia independent of changes in eicosanoid release.
    Schwemmer M; Sommer O; Bassenge E
    Cardiovasc Drugs Ther; 2000 Jun; 14(3):317-27. PubMed ID: 10935154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calpain inhibition decreases inflammatory protein expression in vessel walls in a model of chronic myocardial ischemia.
    Potz BA; Sabe AA; Elmadhun NY; Sabe SA; Braun BJV; Clements RT; Usheva A; Sellke FW
    Surgery; 2017 May; 161(5):1394-1404. PubMed ID: 28024857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.